We recently published a list of Top 10 Trending AI News On Wall Street’s Radar. In this article, we are going to take a look at where Predictive Oncology Inc. (NASDAQ:POAI) stands against other top trending AI news on Wall Street’s radar.
As the DeepSeek-driven sell-off in US AI stocks started to fade, China is claiming advances in another new-age technology that can impact quantum computing stocks globally. Origin Quantum Computing Technology’s prototype received over 20 million remote visits worldwide, marking a major milestone in the mainland’s quantum computing landscape.
Although China has been viewed as lagging behind the US in quantum computing, it could be leading the race when it comes to quantum communications (quantum networking). China has consistently tested secure quantum communications in fiberoptic and satellite networks.
Elsewhere, physicists working in Google’s laboratory developed a new digital-analog quantum simulator that can study and calculate complex physical processes with unprecedented precision. The milestone has the potential to solve different challenges in diverse fields, from solid-state physics to astrophysics.
“Our research demonstrates that it is possible to create superconducting analog-digital quantum processors on a chip and that these are suitable as quantum simulators,” said Andreas Läuchli, one of the theoretical scientists involved in the breakthrough.
We selected AI stocks by reviewing news articles, stock analysis, and press releases. We listed the stocks in ascending order of their hedge fund sentiment taken from Insider Monkey’s database of 900 hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
A doctor in a laboratory, overseeing the development of Artificial Intelligence (AI).
Predictive Oncology Inc. (NASDAQ:POAI)
Number of Hedge Fund Holders: N/A
Predictive Oncology Inc. (NASDAQ:POAI) uses AI and ML to accelerate early drug discovery and facilitate drug development to benefit cancer patients. The company’s AI platform, PEDAL, can forecast the efficacy of medicines on tumor samples with a 92% accuracy, enabling informed selection of drug/tumor type combinations for in-vitro testing.
On February 18th, Predictive Oncology Inc. (NASDAQ:POAI) announced that it built a registry of promising candidates using drug datasets abandoned or discontinued by pharma companies that can be repurposed to achieve efficacy in treating ovarian, colon, and breast cancer.
“Early results show that by running our platform for just eight weeks, we were able to identify compounds for use in one or more tumor types. By precisely measuring only 92 combinations of laboratory experiments on patient tumor samples, the predictive model was capable of making an additional 964 confident predictions, covering a total of 79% of all possible experiments,” said Dr. Arlette Uihlein, Medical Director at Predictive Oncology Inc. “Our active learning AI platform enabled us to efficiently and confidently predict an additional 10x the number of measured experiments, eliminating at least 18 months of wet lab testing and identifying two drugs as having very promising results for use in one or more tumor types. Both of these drugs outperformed a known standard of care drug used to treat colon cancer.”
Overall, POAI ranks 9th on our list of top trending AI news on Wall Street’s radar. While we acknowledge the potential of POAI as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than POAI but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap
Disclosure: None. This article is originally published at Insider Monkey.
